Search

Search Constraints

You searched for: Author/Creator Fazal, Salman

Search Results

2. Case series of unique adverse events related to the use of ibrutinib in patients with B-cell malignancies—A single institution experience and a review of literature. (July 2019)

4. Differences in treatment goals and perception of symptom burden between patients with myeloproliferative neoplasms (MPNs) and hematologists/oncologists in the United States: Findings from the MPN Landmark survey. Issue 3 (30th September 2016)

5. Efficacy and tolerability of treatment with azacitidine for 5 days in elderly patients with acute myeloid leukemia. (16th August 2014)

8. Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study. Issue 10373 (28th January 2023)

9. Myeloproliferative neoplasms (MPNs) have a significant impact on patients' overall health and productivity: the MPN Landmark survey. Issue 1 (December 2016)

10. Myeloproliferative neoplasms (MPNs) have a significant impact on patients' overall health and productivity: the MPN Landmark survey. Issue 1 (December 2016)